Acute lymphoblastic leukemia, version 2.2021: NCCN Clinical Practice Guidelines in Oncology Guidelines
| Authors: | Brown, P. A.; Shah, B.; Advani, A.; Aoun, P.; Boyer, M. W.; Burke, P. W.; DeAngelo, D. J.; Dinner, S.; Fathi, A. T.; Gauthier, J.; Jain, N.; Kirby, S.; Liedtke, M.; Litzow, M.; Logan, A.; Luger, S.; Maness, L. J.; Massaro, S.; Mattison, R. J.; May, W.; Oluwole, O.; Park, J.; Przespolewski, A.; Rangaraju, S.; Rubnitz, J. E.; Uy, G. L.; Vusirikala, M.; Wieduwilt, M.; Lynn, B.; Berardi, R. A.; Freedman-Cass, D. A.; Campbell, M. |
| Title: | Acute lymphoblastic leukemia, version 2.2021: NCCN Clinical Practice Guidelines in Oncology |
| Abstract: | The NCCN Guidelines for Acute Lymphoblastic Leukemia (ALL) focus on the classification of ALL subtypes based on immunophenotype and cytogenetic/molecular markers; risk assessment and stratification for risk-adapted therapy; treatment strategies for Philadelphia chromosome (Ph)-positive and Ph-negative ALL for both adolescent and young adult and adult patients; and supportive care considerations. Given the complexity of ALL treatment regimens and the required supportive care measures, the NCCN ALL Panel recommends that patients be treated at a specialized cancer center with expertise in the management of ALL This portion of the Guidelines focuses on the management of Ph-positive and Ph-negative ALL in adolescents and young adults, and management in relapsed settings. © 2021 Harborside Press. All rights reserved. |
| Journal Title: | Journal of the National Comprehensive Cancer Network |
| Volume: | 19 |
| Issue: | 9 |
| ISSN: | 1540-1405 |
| Publisher: | Harborside Press |
| Date Published: | 2021-09-01 |
| Start Page: | 1079 |
| End Page: | 1109 |
| Language: | English |
| DOI: | 10.6004/jnccn.2021.0042 |
| PUBMED: | 34551384 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | Review -- Export Date: 2 November 2021 -- Source: Scopus |
